Stocks and Investing Stocks and Investing
Thu, June 9, 2022
Wed, June 8, 2022
Tue, June 7, 2022
Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022

Patrick Trucchio Maintained (ARWR) at Strong Buy with Increased Target to $110 on, Jun 3rd, 2022


Published on 2024-10-27 21:24:39 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Increased Target from $100 to $110 on, Jun 3rd, 2022.

Patrick has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $35 on, Wednesday, May 11th, 2022


These are the ratings of the 4 analyists that currently disagree with Patrick


  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $66 on, Tuesday, May 24th, 2022
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $72 on, Wednesday, May 11th, 2022
  • Joel Beatty of "Baird" Upgraded from Hold to Buy and Decreased Target to $60 on, Wednesday, May 11th, 2022
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $80 on, Wednesday, May 11th, 2022